- cafead Aug 26, 2024 at 10:22: AM
via BioNTech has announced the initiation of global clinical trials for BNT116, an mRNA vaccine for the potential treatment of non-small cell lung cancer (NSCLC).
The vaccine is claimed to use the same mRNA technology that proved instrumental in Covid-19 vaccines.
article source
The vaccine is claimed to use the same mRNA technology that proved instrumental in Covid-19 vaccines.
article source